ArticleFrontiers in psychiatry2025
Survey and analysis of the prevalence of tobacco use among patients with severe mental illness at a tertiary specialized psychiatric medical center in China.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PsychoPharm aggregated risk score (PARS): a multidimensional tool to flag high-risk pharmacotherapy in psychiatric patients.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In China, the coexistence of mental illness and tobacco dependence is a major public health issue. With around 300 million smokers and over one million annual smoking-related deaths, the resulting social and economic burdens are considerable. Methods: A cross-sectional study design was employed to gather data on tobacco use, readiness to quit smoking, and nicotine dependence from a random sample of 738 patients diagnosed with severe mental illness. Data analysis, which included descriptive statistics and multivariate logistic regression analysis, was conducted via SPSS 27.0. Results: The findings revealed that the smoking prevalence among patients with severe mental illness was 52.03%, significantly higher than that of the general population. Multifactorial logistic regression analysis indicated that male gender(OR=10.041, 95% CI: 6.499-15.513), Han ethnicity(OR=3.263, 95% CI: 1.053-10.108), worse economic status (OR=2.540, 95% CI: 1.424-4.529), family history of smoking (OR=6.474, 95% CI: 4.211-9.952), outpatient status(OR=2.294, 95% CI: 1.433-3.674), family history of mental illness (OR=1.756, 95% CI: 1.129-2.731), history of drug exposure(OR=2.074, 95% CI: 1.244-3.458), and history of alcohol consumption(OR=5.216, 95% CI: 3.037-8.960) were independent risk factors for smoking in this patient group. Furthermore, there were significant differences in nicotine dependence levels across different psychiatric diagnoses, with patients diagnosed with schizophrenia and bipolar disorder exhibiting higher levels of nicotine dependence compared to those with paranoid disorder who showed lower levels. Conclusions: The study elucidates the complex nature and critical determinants of tobacco use patterns among individuals with severe mental illness, providing a solid scientific foundation for developing targeted intervention strategies. China Clinical Trial Registry registration number: ChiCTR2400088459.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.